Disclosures for "A Case Report: Ophelia Syndrome Associated with a Novel Subtype of Hodgkin’s Lymphoma"
-
Miss LaJeunesse has nothing to disclose.
-
Dr. Abuaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.